Point72 Asset Management’s Evolent Health EVH Stock Holding History

Point72 Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100,000	Closed	-$3.1M	–	1150
2021 Q3	$3.1M	Buy	+100,000	New	+$2.4M	0.01%	739

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's EVH Position: Q1 2026 in Review

Point72 Asset Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 564,954 shares — an estimated $2.26M sold.

Point72 Asset Management first reported a position in EVH in Q2 2017 and held it in 28 quarters. The position peaked at $91.8M in Q4 2022. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Point72 Asset Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
Point72 Asset Management sold 564,954 Evolent Health shares in Q1 2026, an estimated $2.26M.
Point72 Asset Management first reported a position in Evolent Health in Q2 2017 and held it in 28 quarters.
Point72 Asset Management's Evolent Health position peaked at $91.8M in Q4 2022.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.